Table 3B.
Variable | 8 post | 12 post | |
---|---|---|---|
OPAP (mm) | P | 0.579 | 0.528 |
95% CI | −0.59 to 0.92 | −1.33 to 0.69 | |
OPML (mm) | P | 0.668 | 0.498 |
95% CI | −0.68 to 0.44 | −1.90 to 0.94 | |
CPAP (mm) | P | 0.047 | 0.001* |
95% CI | −1.19 to −0.01 | −1.88 to 0.52 | |
CPML (mm) | P | 0.267 | 0.035 |
95% CI | −1.79 to −0.51 | −1.62 to −0.06 | |
TTE (s) | P | 0.157 | 0.001* |
95% CI | −11.70 to 1.94 | −12.44 to 4.52 | |
ATE (%) | P | 0.001* | 0.029 |
95% CI | −28.74 to −11.14 | −20.48 to −1.12 | |
Overall | P | 0.001* | 0.001* |
WOMAC | 95% CI | −16.03 to −4.13 | −17.95 to −9.57 |
Pain | P | 0.001* | 0.325 |
95% CI | −4.73 to −2.47 | −3.75 to 1.27 | |
Stiffness | P | 0.001* | 0.001* |
95% CI | −6.16 to −3.76 | −5.07 to −3.09 | |
Physical function | P | 0.587 | 0.001* |
95% CI | −6.36 to 3.64 | −10.38 to −3.06 |
Denotes a significant effect (p < 0.025). 8 post, 8th post assessment; 12 post, 12th post assessment.